市场调查报告书
商品编码
1410741
植入式心臟整流去颤器(ICD)的全球市场 - 规模,各市场区隔,占有率,法规,偿付,治疗,预测(~2033年)Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告提供全球植入式心臟整流去颤器(ICD)市场相关调查分析,提供各市场区隔的市场规模,市场趋势,竞争情形,COVID-19影响等资讯。
市场模式的主要内容如下列。
已上市的植入式心臟整流去颤器(ICD)与不断变化的竞争格局
世界,地区,国家层级的市场固有考察
透过掌握包含医疗制度概要的真实整体状况来促进对市场的认识。此外在打入市场部门更提供关于给付原则及法规情势之资讯,使您能够更深入地研究市场动态。
对象企业
Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Implantable Cardioverter Defibrillators (ICD) market for the year 2020 and beyond. Cardiac Arrest or Sudden Cardiac Arrest (SCA) is a condition in which abnormal rhythms like Ventricular Fibrillation and Ventricular Tachycardia prevents the heart from pumping blood to the vital organs of the body.
The only treatment of cardiac arrest is to defibrillate the heart to restore heart function which can be done using an external defibrillator; however, the chances of surviving an out of hospital cardiac arrest are thin. For patients with high risk of SCA, such as those with coronary artery disease or cardiomyopathy, a physician may prescribe anti-arrhythmic medication or an Implantable Cardioverter Defibrillator(ICD) .
Original implantable cardioverter-defibrillator was designed to detect only ventricular fibrillation and not for ventricular tachycardia. ICDs are used to record the heart's activity and treat dangerous ventricular arrhythmias with an electrical shock or pulse to the heart.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Implantable Cardioverter Defibrillators (ICD) and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Biotronik SE & Co KG, MicroPort Scientific Corp.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable